[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621562":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":34,"locations":24,"responsibleParty":43,"collaborators":24,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":24,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":71,"whyStopped":24,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":24},{"fullName":5,"class":6},"Region Skane","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Dietary intervention without feedback","ACTIVE_COMPARATOR","All participants in this arm will be recommended SSRD, but they do not receive any information about changes in their metabolic profiles after the 6-week control",[13],"Other: Dietary intervention with SSRD without any feedback on metabolic profile",{"label":15,"type":10,"description":16,"interventionNames":17},"Dietary intervention with feedback","All participants in this arm will be recommended SSRD, and they receive information about changes in their metabolic profiles after the 6-week control",[18],"Other: Dietary intervention with SSRD in combination with feedback information about the metabolic profile",[20,25],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"Dietary intervention with SSRD in combination with feedback information about the metabolic profile","All participants will recieve a dietary intervention. They will be informed at the 6-week control about the changes in metabolic profile since study start.",[15],null,{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"Dietary intervention with SSRD without any feedback on metabolic profile","All particpants will receive informaiton about the SSRD diet. However, the participants will not be informed about the metabolic profile at the 6-week control",[9],[30],{"name":31,"affiliation":32,"role":33},"Cecilia Kennbäck, Registered Nurse","Department of Internal Medicine, Skåne University Hospital, 20502 Malmö","STUDY_CHAIR",[35,40],{"name":36,"role":37,"phone":38,"phoneExt":24,"email":39},"Bodil Ohlsson, Professor","CONTACT","+46 040 33 23 23","bodil.ohlsson@med.lu.se",{"name":41,"role":37,"phone":24,"phoneExt":24,"email":42},"Olle Melander, Professor","olle.melander@med.lu.se",{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Bodil Ohlsson","Professor","100621562","ssrd-and-overweight-100621562",false,"NCT07372235","SSRD and Overweight","Comparison at Overweight Between Those Who Receive Feedback Concerning Their Metabolic Profile or Not During an Intervention With Modified Starch- and Sucrosereduced Diet (SSRD)","SSRD","Inclusion Criteria:\n\n* Ålder 18-70 år och språkkunskaper i svenska så att de kan tillgodogöra sig kostinformationen och ifylla formulären.\n* BMI ≥25 kg\u002Fm2\n\nExclusion Criteria:\n\n* Allvarlig födoämnesallergi\n* Allvarlig hjärt, lung, kardiovaskulär, magtarm, malign eller psykisk sjukdom\n* Pågående ätstörning\n* Graviditet\n* Står redan på en diet såsom vegan diet, regelbunden fasta \\>15 timmar per dag, eller låg kolhydrat hög fett (LCHF) diet de senaste 3 månaderna\n* Alkohol och\u002Feller drogberoende\n* Stora ändringar i kroppsvikt de senaste 3 månaderna (≥3 kg)\n* Står på viktreducerande läkemedel eller läkemedel som typ GLP-1 analoger","ALL","18 Years","70 Years",{"count":59,"type":60},300,"ESTIMATED","INTERVENTIONAL",[63],"NA","The investigators have previously found that a starch- and sucrosereduced diet (SSRD) has led decreased gastrointestinal symptoms in patients with irritabel bowel syndrome (IBS). At the same time, investigators found that the weight was reduced and the nutrient intake was improved with a more favorable metabolic profile. However, it is a challenge to change lifestyle, and most persons fail to keep on with an improved diet for a long time. Investigators therefore now want to conduct a clinical trial with SSRD in overweight\u002Fobesity for 3 months. Persons with a BMI \\>25 kg\u002Fm2 will be included. To examine whether a feedback about improved metabolic profile enhances the compliance, participants will be randomized to be informed or not about the metabolic profile after the 6-week visit. Investigator´s hypothesis is that information about the improvement in the metabolic profile should increase the motivation and compliance in the patients, and thereby render better effects.",[66],"Overweight (BMI > 25)",[68,53,69,70],"overweight","metabolomics","feedback on dietary efficiency","NOT_YET_RECRUITING","2026-04-28",{"date":74,"type":75},"2026-04-29","ACTUAL",{"date":77,"type":60},"2026-09-01",{"date":79,"type":60},"2032-12-31",{"name":5,"class":6}]